Stockreport

resTORbio Announces Positive Topline Results in Phase 2b Trial of RTB101

RESTORBIO  (TORC) 
Last restorbio earnings: 3/12 07:30 am Check Earnings Report
PDF -- Statistically significant and clinically meaningful 30.6% reduction in the percentage of patients with one or more laboratory-confirmed respiratory tract infections ( [Read more]